Liability Reform Foes Point To COX-2s, Attack “FDA Defense”
This article was originally published in The Tan Sheet
Executive Summary
COX-2 safety concerns have provided opponents of "FDA defense" provisions with a weapon against medical liability legislation as President Bush launches a campaign for his tort reform agenda